Barely a day goes by without major developments coming out from China, and an escalating trade dispute with the US and a slowing domestic economy are among the most recent headlines. For the pharma sector, the rapid roll-out of a massive centralized bidding scheme in major cities is adding to the growing list of operating uncertainties.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?